InnoBation Bio
英百瑞
InnoBation Bio
Biotech/Healthcare
Founded in 2014, Hangzhou Yingbairui Biopharmaceutical Technology focuses on immunotherapies for cancer and immune-related diseases. Since 2016, it has specialized in developing innovative universal, off-the-shelf CAR-NK cell therapies.
Latest round: Series B (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-02-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.